PublicationsImpact of the international reference pricing on access to standard therapy drugs for copd

Impact of the international reference pricing on access to standard therapy drugs for copd

Bibliographic information

Publication year: 2018
Category: AFG — Abstracts of papers from foreign scientific conferences
CREPČ / EPCA ID: 0033899
Document type: Journal article
Source: Value In Health
ISSN (Source): 1098-3015
Volume: Vol. 21, suppl. 3 (2018), p. 415-416
Source publication year: 2018
Language: English
Research areas: 180 — Medical, pharmaceutical and non-medical health sciences
Links: ARL CREPČ

Bibliographic record

VIŠŇANSKÝ, Martin - BUTALOVÁ, Anna. Impact of the international reference pricing on access to standard therapy drugs for copd [Dopad medzinárodného referencovania cien na dostupnosť štandardnej terapie pre liečbu CHOCHP]. In: ISPOR Europe 2018-New perspectives for improving 21st century health systems. Value In Health. 2018. ISSN 1098-3015, Vol. 21, suppl. 3 (2018), p. 415-416. (2018: 5.037 - IF, 97 - H-index, 6.131 - IF 5y, 1.836 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 2.082 - ABDC).

Publication authors

Author	Role	Share
Martin Višňanský	Author	50.000 %
Anna Butalová	Author	50.000 %

Metrics

IF 5.037IF5 6.131SJR Q 1JCR Q 1SJR 1.836H-index 97ABDC 2.082Metrics year 2018